Shuguftha Naz
Overview
Explore the profile of Shuguftha Naz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naz S, Banerjee T, Totsingan F, Woody K, Gross R, Santra S
Nanotheranostics
. 2021 Apr;
5(4):391-404.
PMID: 33912379
Non-Small-Cell Lung Cancer (NSCLC) has gained resistance to common chemo- and radiotherapy due to the oncogenic K-RAS mutations. In this work, lactonic sophorolipids (LSL), a constituent of natural sophorolipids known...
2.
Heckert B, Banerjee T, Sulthana S, Naz S, Alnasser R, Thompson D, et al.
ACS Macro Lett
. 2017 Nov;
6(3):235-240.
PMID: 29104818
In this study, we have synthesized a new hyperbranched polyester polymer containing sulfur-pendants (HBPE-S) in the branching points. This HBPE-S polymer is composed of spherical shaped, aliphatic three-dimensional architecture with...
3.
Naz S, Beach J, Heckert B, Tummala T, Pashchenko O, Banerjee T, et al.
Nanomedicine (Lond)
. 2017 Feb;
12(5):545-553.
PMID: 28181459
Despite advances in understanding the factors that cause many neurodegenerative diseases (NDs), no current therapies have yielded significant results. Cerium oxide nanoparticles (CeONPs) have recently emerged as therapeutics for the...
4.
Sulthana S, Banerjee T, Kallu J, Vuppala S, Heckert B, Naz S, et al.
Mol Pharm
. 2017 Jan;
14(3):875-884.
PMID: 28081601
K-RAS driven non-small-cell lung cancer (NSCLC) represents a major cause of death among smokers. Recently, nanotechnology has introduced novel avenues for the diagnosis and personalized treatment options for cancer. Herein,...